Illustrative image of compounded semaglutide injection offered through NexLife’s physician-led telehealth program. Eligible patients receive provider-directed treatment through licensed pharmacy partners with flat-rate pricing across prescribed doses. Compounded semaglutide is not FDA-approved.
Illustrative image of compounded semaglutide injection offered through NexLife’s physician-led telehealth program. Eligible patients receive provider-directed treatment through licensed pharmacy partners with flat-rate pricing across prescribed doses. Compounded semaglutide is not FDA-approved.